These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 30904169)
1. Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer. Khalaj-Kondori M; Hosseinnejad M; Hosseinzadeh A; Behroz Sharif S; Hashemzadeh S Curr Probl Cancer; 2020 Feb; 44(1):100471. PubMed ID: 30904169 [TBL] [Abstract][Full Text] [Related]
2. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer. Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004 [TBL] [Abstract][Full Text] [Related]
4. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis. Li DJ; Feng ZC; Li XR; Hu G World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376 [TBL] [Abstract][Full Text] [Related]
5. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671 [TBL] [Abstract][Full Text] [Related]
6. Jiao Y; Li Y; Fu Z; Hou L; Chen Q; Cai Y; Jiang P; He M; Yang Z Dis Markers; 2019; 2019():9037131. PubMed ID: 31781311 [TBL] [Abstract][Full Text] [Related]
7. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression. Muthamilselvan S; Raghavendran A; Palaniappan A PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405 [TBL] [Abstract][Full Text] [Related]
8. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway. Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770 [TBL] [Abstract][Full Text] [Related]
10. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan. Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582 [TBL] [Abstract][Full Text] [Related]
11. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients. Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791 [TBL] [Abstract][Full Text] [Related]
13. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967 [TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers. Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852 [TBL] [Abstract][Full Text] [Related]
16. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer. Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031 [TBL] [Abstract][Full Text] [Related]
17. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients. Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068 [TBL] [Abstract][Full Text] [Related]
18. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer. Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405 [TBL] [Abstract][Full Text] [Related]
19. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array. Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652 [TBL] [Abstract][Full Text] [Related]